CB Scientific, Inc. (CBSC)
| Market Cap | 6.44M |
| Revenue (ttm) | 50.37K |
| Net Income (ttm) | -640.55K |
| Shares Out | 162.17M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,000 |
| Average Volume | 53,703 |
| Open | 0.0397 |
| Previous Close | 0.0397 |
| Day's Range | 0.0397 - 0.0400 |
| 52-Week Range | 0.0210 - 0.1490 |
| Beta | 1.63 |
| RSI | 50.59 |
| Earnings Date | n/a |
About CB Scientific
CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide improved compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. The company is based in Las Vegas, Nevada. [Read more]
Financial Performance
Financial StatementsNews
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
LAS VEGAS, NV / ACCESS Newswire / February 25, 2025 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitor...
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
LAS VEGAS, NV / ACCESSWIRE / October 3, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring pro...
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring pro...
CB Scientific, Inc. Concludes its Annual Meeting of Stockholders
Shareholders endorse name change to Cardiac Biotech Solutions, Inc. subject to regulatory approval LAS VEGAS, NV / ACCESSWIRE / March 19, 2024 / CB Scientific, Inc. (OTCQB:CBSC) ("CBSC" or the "Compan...
CB Scientific, Inc. 2023 Year in Review
Recap includes transformational matters affecting the Company's position to manage impending growth LAS VEGAS, NV / ACCESSWIRE / January 11, 2024 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Com...
CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement
Your Heart Protector Corp. to market the Company's products and provide associated monitoring services throughout Canada LAS VEGAS, NV / ACCESSWIRE / March 9, 2023 / CB Scientific. Inc. (OTCQB:CBSC) (...
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
Updated product to include significant operating improvements and material design advances over the current offering ESCONDIDO, CA / ACCESSWIRE / September 6, 2022 / CB Scientific. Inc.(OTCQB:CBSC) ("...
CB Scientific, Inc. (CBSC) and Shenzhen Pump Medical Co., Ltd. Announce Cooperative Manufacturing Agreement for Chinese Market
Shenzhen Pump Medical Co. Ltd. to formally become the recognized manufacturer of record for CBSC's myCam device, cloud-based software, and smartphone app in China.
CB Scientific, Inc. Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device
Enhanced product to include significant operating enhancements and material design advances over the current offering ESCONDIDO, CA / ACCESSWIRE / May 24, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBS...
CB Scientific, Inc. Welcomes James Ott as Chief Technology Officer
Newly created position to spearhead technological innovation in the next stage of growth ESCONDIDO, CA / ACCESSWIRE / May 3, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a design...
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market
Shareholders to benefit from greater transparency and improved liquidity ESCONDIDO, CA / ACCESSWIRE / April 6, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufactur...
CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP
Achieving Major Milestone Squarely Positions the Company for Uplisting to the OTCQB® Venture Market ESCONDIDO, CA / ACCESSWIRE / March 15, 2022 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Co...
CB Scientific, Inc. Concludes Its Special Meeting of Stockholders
Commanding shareholder approval better positions management to attain enterprise business objectives going forward ESCONDIDO, CA / ACCESSWIRE / January 18, 2022 / CB Scientific, Inc. (OTC PINK:CBSC) (...
CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022
Agenda includes transformational matters affecting the Company's position to manage impending growth ESCONDIDO, CA / ACCESSWIRE / January 4, 2022 / CB Scientific, Inc. (OTC PINK: CBSC) ("CBSC" or the ...
CB Scientific, Inc. Enters Beta-testing Phase for Its Updated Proprietary My-Cam Cardiac Event Monitor
Updates to provide device improvements while maintaining the innovative core-functionality of CBSC's state-of-the-art cardiac event monitor ESCONDIDO, CA / ACCESSWIRE / December 14, 2021 / CB Scientif...
CB Scientific, Inc. Executes Manufacturing Letter of Intent with Shenzhen Pump Medical System Co., Ltd.
Partnership to provide high volume manufacturing capability and facilitate obtaining requisite government approvals ESCONDIDO, CA / ACCESSWIRE / December 7, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ...
CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders
Agenda to include matters necessary to better position the company for anticipated growth and development ESCONDIDO, CA / ACCESSWIRE / November 30, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" o...
CB Scientific Files Application to Uplist to the OTCQB Venture Market
Upgraded listing would provide increased transparency and enhanced trading efficiency ESCONDIDO, CA / ACCESSWIRE / November 16, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is ...
CB Scientific Announces Addition of Brooke Martellaro as Chief Financial Officer
Seasoned finance executive and business leader to add significant incremental competencies to the Company ' s executive management team ESCONDIDO, CA / ACCESSWIRE / November 2, 2021 / CB Scientific. I...
CB Scientific, Inc. Appoints Paul Danner as Chairman
The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated success ESCONDIDO, CA / ACCESSWIRE / October 28, 2021 / CB Scientific, Inc. (OTC...
CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP
CBSC begins independent Financial Audit through MaloneBailey, LLP. ESCONDIDO, CA / ACCESSWIRE / October 5, 2021 / CB Scientific.
CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand
Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd.
CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC
ESCONDIDO, CA/ ACCESSWIRE/ September 23, 2021 / CB Scientific. Inc. ( OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of remote cardiac monitoring products and services (my-Cam™ monitor and my-C...
CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand
Successful introductory product trials result in an agreement by three major hospital chains to use the my-Cam device ESCONDIDO, CA / ACCESSWIRE / March 16, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ...
CB Scientific, Inc. Announces Appointment of New Director for Asia Pacific
CBSC has appointed Jeslie Chui as Director of Business Development Asia PacificEscondido, California--(Newsfile Corp. - March 2, 2021) - CB Scientific. Inc. (OTC Pink: CBSC) ("CBSC" or the "Company"),...